EPO Patent EP4629967A1: Perfluorinated Micelles Medical Uses
Summary
The European Patent Office has published patent application EP4629967A1 concerning perfluorinated micelles and their medical uses. The application lists Commissariat à l'Energie Atomique et aux Energies Alternatives, Université Paris-Saclay, Centre National de la Recherche Scientifique, and Institut National de la Sante et de la Recherche Medicale (INSERM) as applicants.
What changed
This document is a publication of a European patent application (EP4629967A1) related to perfluorinated micelles and their medical applications. The patent application was published on March 18, 2026, with several French research institutions listed as applicants, including Commissariat à l'Energie Atomique et aux Energies Alternatives, Université Paris-Saclay, Centre National de la Recherche Scientifique, and INSERM.
This publication represents the grant of a patent, which provides exclusive rights to the inventors and applicants for their invention. Companies operating in the pharmaceutical or medical device sectors, particularly those involved in drug delivery systems or novel therapeutic agents, should be aware of this patent. While this is a patent grant and not a regulatory rule, it may impact research and development, licensing, and market exclusivity for related technologies within the designated European states.
Source document (simplified)
PERFLUORINATED MICELLES AND MEDICAL USES THEREOF
Publication EP4629967A1 Kind: A1 Mar 18, 2026
Applicants
Commissariat à l'Energie Atomique et aux Energies
Alternatives, Université Paris-Saclay, Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche
Medicale (INSERM)
Inventors
DORIS, Eric, GRAVEL, Edmond, GODEL, Sophia, TRUILLET, Charles, PORCEL, Erika, JAMGOTCHIAN, Lucie
IPC Classifications
A61K 9/00 20060101AFI20240614BHEP A61K 9/107 20060101ALI20240614BHEP A61K 41/00 20200101ALI20240614BHEP A61K 51/04 20060101ALI20240614BHEP A61K 51/12 20060101ALI20240614BHEP C07C 323/52 20060101ALI20240614BHEP A61K 47/10 20170101ALI20240614BHEP A61K 47/20 20060101ALI20240614BHEP C08G 65/333 20060101ALI20240614BHEP C08G 65/334 20060101ALI20240614BHEP C08G 65/337 20060101ALI20240614BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.